Cohen & Steers Inc(CNS) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 23.54 | EPS (ttm) | 3.26 | Insider Own | 46.1% | Shs Outstand | 51.4M | Perf Week | -0.74% |
| Market Cap | 3.94B | Forward P/E | 19.41 | EPS next Y | 13.34% | Insider Trans | -0.07% | Shs Float | 27.7M | Perf Month | -9.07% |
| Enterprise Value | 4.12B | PEG | 1.48 | EPS next Q | 0.93 | Inst Own | 56.7% | Short Float | 4.19% | Perf Quarter | 0.78% |
| Income | 0.17B | P/S | 6.43 | EPS this Y | 12.78% | Inst Trans | 5.71% | Short Ratio | 4.14 | Perf Half Y | 21.37% |
| Sales | 0.61B | P/B | 6.69 | EPS next 5Y | 13.1% | ROA | 20.38% | Short Interest | 1.16M | Perf YTD | 22.11% |
| Book/sh | 11.46 | P/C | 66.64 | EPS past 3/5Y | -5.01% 13.58% | ROE | 30.11% | 52W High | -11.44% ($86.56) | Perf Year | 7.84% |
| Cash/sh | 1.15 | P/FCF | 20.46 | Sales past 3/5Y | -0.15% 6.24% | ROIC | 23.25% | 52W Low | 31.29% ($58.39) | Perf 3Y | 22.38% |
| Dividend Est. | $2.68 (3.5%) | EV/EBITDA | 19.09 | EPS Y/Y TTM | 2.98% | Gross Margin | 86.06% | Volatility(W/M) | 3.2% 3.1% | Perf 5Y | -10.42% |
| Dividend TTM | 2.63 | EV/Sales | 6.73 | Sales Y/Y TTM | 12.59% | Oper. Margin | 33.56% | ATR (14) | 2.41 | Perf 10Y | 122.8% |
| Dividend Ex-Date | 2026/8/10 | Quick Ratio | 5.22 | EPS Q/Q | 32.9% | Profit Margin | 27.45% | RSI (14) | 36.58 | Recom | 2.67 |
| Dividend Gr. 3/5Y | 4.07% 9.71% | Current Ratio | 5.22 | Sales Q/Q | 22.37% | SMA20 | -5.42% ($81.05) | Beta | 1.21 | Target Price | $74.5 |
| Payout | 83.4% | Debt/Eq | 0.23 | Earnings | 2026/7/16 | SMA50 | -5.38% ($81.02) | Rel Volume | 1.08 | Prev Close | $77.17 |
| Employees | 424 | LT Debt/Eq | 0.23 | EPS/Sales Surpr. | -0.58% 1.6% | SMA200 | 8.71% ($70.52) | Avg Volume(3M) | 0.28M | Price | $76.66 |
| IPO | 2004/8/13 | Option/Short | Yes/Yes | Trades | 4311 | Volume | 301,562 | Change | -0.66% |
Company
CNS is a Financial sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
💰 A global asset management firm specializing in real-asset investing. The company focuses on managing real-asset and income-generating assets such as REITs, infrastructure, commodities, and preferred stocks, generating fee revenue based on assets under management. It is a specialized asset manager in the real-asset space.
Over the past 1 year, roughly in the middle
11% below its 1-year high.
CNS makes money exceptionally well
Strong earnings and excellent financial health
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +12.8% this year.
Tap to view numbers
The price looks about right
Trading at 23.5 times earnings.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Would have changed by +22.4% if bought 5 years ago.
Tap to view numbers
Dividends are paid consistently
Pays 3.50% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 56.7%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
BLUI 0.10%
GABF 0.05%
PRVT 0.03%
AAUM 0.03%
ABLS 0.02%It ranks #4 in the industry
Based on market cap of $4B.
CNS $4B PER 23.5
BLK $173B PER 26.4
BX $156B PER 28.1
KKR $91B PER 32.2
FAQ
What kind of company is CNS?
CNS belongs to the Financial sector and operates in the Asset Management industry.
What is the market cap of CNS?
The market cap of CNS is approximately $3.9B, ranking 1,573 within its sector.
Does CNS pay dividends?
CNS has a dividend yield of approximately 3.50%, with an annual dividend of $2.68.
What is the P/E ratio of CNS?
CNS has a P/E ratio of approximately 23.5x, which can be used to assess its valuation relative to the Financial sector average.
What is the 52-week high and low for CNS?
CNS has recorded a 52-week high of $86.56 and a low of $58.39.
